[go: up one dir, main page]

FR3127690B1 - Combination product to relieve sore throats - Google Patents

Combination product to relieve sore throats Download PDF

Info

Publication number
FR3127690B1
FR3127690B1 FR2110535A FR2110535A FR3127690B1 FR 3127690 B1 FR3127690 B1 FR 3127690B1 FR 2110535 A FR2110535 A FR 2110535A FR 2110535 A FR2110535 A FR 2110535A FR 3127690 B1 FR3127690 B1 FR 3127690B1
Authority
FR
France
Prior art keywords
combination product
sore throats
relieve sore
throats
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2110535A
Other languages
French (fr)
Other versions
FR3127690A1 (en
Inventor
Eugénie Bertrand
Marilyn Gentilhomme
Aurore Vigneau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Urgo Recherche Innovation et Developpement
Original Assignee
Urgo Recherche Innovation et Developpement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urgo Recherche Innovation et Developpement filed Critical Urgo Recherche Innovation et Developpement
Priority to FR2110535A priority Critical patent/FR3127690B1/en
Priority to PCT/EP2022/077471 priority patent/WO2023057390A1/en
Publication of FR3127690A1 publication Critical patent/FR3127690A1/en
Application granted granted Critical
Publication of FR3127690B1 publication Critical patent/FR3127690B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/577Malvaceae (Mallow family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2063Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2068Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Insects & Arthropods (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Jellies, Jams, And Syrups (AREA)

Abstract

La présente invention a pour objet un produit de combinaison comprenant à titre de substances actives, au moins du miel, de la propolis, de l’erysimum et de la mauve pour aider à soulager les maux de gorges. L'invention concerne enfin l'utilisation d'un produit de combinaison tel que précédemment défini pour le traitement des maux de gorges.The present invention relates to a combination product comprising, as active substances, at least honey, propolis, erysimum and mallow to help relieve sore throats. The invention finally relates to the use of a combination product as previously defined for the treatment of sore throats.

FR2110535A 2021-10-05 2021-10-05 Combination product to relieve sore throats Active FR3127690B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR2110535A FR3127690B1 (en) 2021-10-05 2021-10-05 Combination product to relieve sore throats
PCT/EP2022/077471 WO2023057390A1 (en) 2021-10-05 2022-10-03 Combination product for relieving sore throats comprising honey, propolis, erysimum and mallow

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2110535A FR3127690B1 (en) 2021-10-05 2021-10-05 Combination product to relieve sore throats
FR2110535 2021-10-05

Publications (2)

Publication Number Publication Date
FR3127690A1 FR3127690A1 (en) 2023-04-07
FR3127690B1 true FR3127690B1 (en) 2024-07-26

Family

ID=79601648

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2110535A Active FR3127690B1 (en) 2021-10-05 2021-10-05 Combination product to relieve sore throats

Country Status (2)

Country Link
FR (1) FR3127690B1 (en)
WO (1) WO2023057390A1 (en)

Also Published As

Publication number Publication date
WO2023057390A1 (en) 2023-04-13
FR3127690A1 (en) 2023-04-07

Similar Documents

Publication Publication Date Title
Cabrales et al. Nitric oxide protection against murine cerebral malaria is associated with improved cerebral microcirculatory physiology
SV1995000007A (en) DERIVATIVES OF 5-SUBSTITUTED MYCOPHENOLIC ACID.
FI961438A7 (en) beta-amyloid protein production inhibitors
ECSP066365A (en) ANILINO PURINAS REPLACED IN POSITION 6 USEFUL AS RTK INHIBITORS
ATE84968T1 (en) MEDICATIONS CONTAINING AZELASTINE FOR NOSE AND/OR EYE USE.
ES2145992T3 (en) MEDICATION FORM USED TO ADMINISTER ACTIVE SUBSTANCES TO WOUNDS.
DE69034223D1 (en) Sertraline for the treatment of social phobia
ATE406371T1 (en) ACTIVE INGREDIENTS FOR THE DECREASE OF AMYLOID PRECURSOR PROTEIN AND THE TREATMENT OF INFECTION, AND THEIR METHODS OF USE
ATE284693T1 (en) USE OF DOPAMINE-D 3 RECEPTOR ANTAGONISTS FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF RENAL DISORDERS
ATE201597T1 (en) ADMINISTRATION OF RILUZOLE FOR THE TREATMENT OF NEURO-AIDS
KR970706002A (en) Use of Aromatase Inhibitors in the Preparation of a Drug for Relative Androgen Deficiency in Men in the Preparation of a Medicament for the Treatment of Relative Androgen Deficiency in Male
AR028959A1 (en) USE OF RAPAMYCIN FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT CARDIOVASCULAR DISEASES
FR3075642B1 (en) KAPOKIER FLOWER EXTRACT AND COSMETIC, PHARMACEUTICAL OR DERMATOLOGICAL COMPOSITIONS CONTAINING IT
FR2421620A1 (en) MICROBICIDE COMPOSITION BASED ON 4,5-DICHLORO-1,2-DITHIOL-3-ONE AND ITS APPLICATION
DE59914712D1 (en) USE OF INHIBITORS OF THE KQT1 CHANNEL FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DISEASES CAUSED BY HELMINTH AND ECOPOPARASITES
FR3127690B1 (en) Combination product to relieve sore throats
EE200100188A (en) Optically active pyridyl-4H-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
FR3125704B1 (en) Combination product to relieve symptoms of sore throats
FR3097744B1 (en) Combination product to help maintain the body's natural defenses
BR0010084A (en) Pharmaceutical composition, processes to prevent, treat or inhibit the development of simple retinopathy or proliferative retinopathy, and to increase retinal potential or mammalian retinal edema, and, use of a compound
AR120931A1 (en) FUNGICIDES TO PREVENT AND CONTROL FUNGAL PATHOGENS
FR2885491B1 (en) TREATMENT OF KERATINIC DROUGHT WITH GLYCERIDES
DE60213464D1 (en) AMLOPIDINE BEZYLATE TABLETS WITH IMPROVED STABILITY
MA26698A1 (en) LIQUID CONCENTRATED PHARMACEUTICAL COMPOSITION OF SERTRALINE AND PROCESS FOR ITS PREPARATION
ATE283061T1 (en) USE OF A COMPOUND CONTAINING POLLEN EXTRACT FOR THE TREATMENT OF EDEMA

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20230407

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5